One would think that this must draw attention by itself, great news for mnd suffers, first treatment of its kind for MND and little to no adverse affects.
I thank all participants in the trial and also thank those who have and continue to carry out the trial.
A possible treatment I guess I should say, and developed by a small Australian company.
Come on big pharmas this had great potential not only for mnd but human cancer.
- Forums
- ASX - By Stock
- PAA
- Ann: MND Biomarkers and Pharmacodynamics Results
Ann: MND Biomarkers and Pharmacodynamics Results, page-61
-
- There are more pages in this discussion • 336 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.0¢ |
Change
0.015(8.57%) |
Mkt cap ! $89.98M |
Open | High | Low | Value | Volume |
17.5¢ | 19.0¢ | 17.5¢ | $310.3K | 1.669M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 29264 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 29717 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 20000 | 0.190 |
2 | 29264 | 0.185 |
3 | 132730 | 0.180 |
7 | 547896 | 0.175 |
2 | 20882 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 82422 | 1 |
0.195 | 404100 | 7 |
0.200 | 285205 | 12 |
0.205 | 249875 | 2 |
0.210 | 225000 | 2 |
Last trade - 16.10pm 24/09/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online